Skip to main content
. Author manuscript; available in PMC: 2017 Sep 22.
Published in final edited form as: Vaccine. 2016 Aug 26;34(41):5026–5033. doi: 10.1016/j.vaccine.2016.07.053

Table 2.

Cumulative Tdap vaccination rates at baseline and the end of the Year 1 randomized controlled cluster trial, by city

Year 1 – Randomized Controlled Cluster Trial
Intervention sites Control sites

Site Total N % vaccinated by 5/31/2013 % vaccinated by 5/31/2014 Site Total N % vaccinated By 5/31/2013 % vaccinated By 5/31/2014
Pittsburgh

B 529 16.6 21.1 N 2,102 31.5 35.1
C 2,179 42.7 52.2 O 4,324 30.1 37.8
D 3,224 12.2 15.3 R 2,534 33.5 40.2
E 1,392 19.1 22.0 S 1,045 38.5 46.8
F 3,611 59.3 70.8 U 2,612 59.5 65.4
G 417 11.2 14.1 W 224 42.8 57.1
H 306 4.2 5.5 X 1,010 48.1 56.3
J 603 19.5 34.3 Y 3,334 23.4 29.7
K 330 6.7 9.1 --
M 595 31.7 42.2 --

Total 13,186 34.7 42.4* Total 17,185 36.4 42.8*

Total percentage point difference from baseline to end of Year 1 7.7** 6.4**

Houston
A 4,880 45.7 56.5 P 6,388 40.7 47.9
I 8,527 20.2 24.6 T 5,547 35.0 45.4
L 5,867 41.1 58.5 V 8,969 32.1 38.2

Intervention total 19,274 33.1 43.0* Control total 20,904 35.5 43.1*
Total percentage point difference from baseline to end of Year 1 9.9 Total percentage point difference from baseline to end of Year 1 7.6

All groups 70,549 35.1 42.7* Total percentage point difference from baseline to Year 1 7.6
*

P<0.001 for difference between Baseline and end of Year 1

**

P<0.001 for difference between Intervention and Control groups in Pittsburgh

P<0.001 for difference between Intervention and Control groups in Houston